Abstract: Enzymatic hydrolysis of the pyrophosphate bond of CDPdiglyceride (CDP-DG), previously shown to occur in bacteria, is demonstrable in mammalian tissues. Activity was enriched in a lysosomal fraction obtained from guinea pig cerebral cortex and was purified 92-fold relative to the homogenate by a combination of XM-300 ultrafiltration and DEAE-cellulose column chromatography. When incubated with CDP-dipalmitin, the purified enzyme produced stoichiornetric amounts of CMP and phosphatidate. dCDP-DG served as a substrate, while ADP-DG was an inhibitor, as were 5'-AMP and 5'-dAMP. CDP-DG hydrolysis was not affected by the presence of excess amounts of CDP-choline, CDP-glycerol, sodium pyrophosphate, or cyclic CDP-diglyceride (CDP-DG; 5'-cytidine diphospho-1,2-diacyl-sn-glycerol) is an obligatory intermediate for the formation of the bacterial phospholipids. In eukaryotic cells, the liponucleotide is the biosynthetic precursor of two classes of phospholipids, the phosphatidylinositols and the phosphatidylglycerols. CDP-DG has been isolated in minute amounts from mammalin liver (Thompson and MacDonald, 1975 ) and brain (Thompson and MacDonald, 1976) and has been found to be highly enriched in stearate and arachidonate, a pattern which closely resembles that observed in isolated diacylglycerol as well as in the phosphatidylinositols, but not seen in the phosphatidylglycerol series or in isolated phosphatidate (Thompson and MacDonald, 1976) .
CDP-diglyceride (CDP-DG; 5'-cytidine diphospho-1,2-diacyl-sn-glycerol) is an obligatory intermediate for the formation of the bacterial phospholipids. In eukaryotic cells, the liponucleotide is the biosynthetic precursor of two classes of phospholipids, the phosphatidylinositols and the phosphatidylglycerols. CDP-DG has been isolated in minute amounts from mammalin liver (Thompson and MacDonald, 1975 ) and brain (Thompson and MacDonald, 1976) and has been found to be highly enriched in stearate and arachidonate, a pattern which closely resembles that observed in isolated diacylglycerol as well as in the phosphatidylinositols, but not seen in the phosphatidylglycerol series or in isolated phosphatidate (Thompson and MacDonald, 1976) .
The low rate of synthesis of CDP-DG and its low steady state content in brain and liver suggest that enzymes involved in its synthesis and degradation may be part of a regulatory mechanism in lipid Tyramine (40-60 mCi/mmol) was a product of New England Nuclear Corp., Boston, Massachusetts.
[3H]-dCDP-diglyceride (0.23 mCi/mmol, labeled in the cytidine moiety) and unlabeled ADP-diglyceride were the generous gift of Dr. W. Dawhan. Dipalmitoyl-snglycerol-3-phosphate (L-a-dipalmitoylphosphatidate), AMP, 2-deoxy AMP, CDP, D-ribose 5'-monophosphate, adenosine 5'-monosulphate, adenosine 5'-monophosphoramidate, tetrasodium pyrophosphate, cyclic 3',5',-AMP, adenosine, CMP, IMP, CDP-choline, CDPglycerol, and dipalmitoyl CDP-DG were products of Sigma Chemical Co., St. Louis, Missouri. Arabinosyl cytosine (ara-C), ara-CMP, arabinosyl adenosine (ara-A), and ara-AMP were obtained from P-L Biochemicals Inc., Milwaukee, Wisconsin. a,P-Methylene ATP and /3,y methylene ATP were purchased from Miles Laboratories, Inc., Elkhart, Indiana. Adenosine 5'-O-thiomonophosphate was the product of Boehringer-Mannheim Biochemicals, Indianapolis, Indiana. Unlabeled dCDP-DG and 1-palmitoyl glycerol-3-phosphate (lysophosphatidate) were obtained from Serdary Research Laboratories, London, Ontario; Triton X-100 from Rohm and Haas Co., Philadelphia, Pennsylvania; Unisil from the Clarkson Chemical Co., Williamsport, Pennsylvania.
Preparation of Subcellular Fractions
For each experiment, three male guinea pigs (300-350 g) were killed by stunning and exsanguination. Whole brains rostra1 to the colliculi were removed within 2 min and rinsed in 0.32 M-SUCrOSe. The cerebral cortices were then separated from underlying midbrain structures and excess white matter removed with a blunt spatula. The tissue (approximately 1.5-2.0 g wet weighvbrain) was homogenized in a glass homogenizer with 9 volumes of 0.32 M-SUCTOSe. Subsequent fractionation of the homogenate was carried out as previously described (Schacht and Agranoff, 1972) . The postmitochondrial supernatant was further separated into microsomal (P3) and high-speed soluble fractions (S,) by centrifugation at 105,000 g for 60 min. Subcellular fractions were resuspended in 0.32 Msucrose to yield protein concentrations of 2-10 mg proteidml.
A subfraction enriched in lysosomes was prepared from the P2 pellet (crude mitochondria1 fraction) by the "chemical field method" of Lisman et al. (1978) . The mitochondria-enriched fraction was taken as "fraction 1" after low-speed centrifugation of the P2 fraction in the presence of succinate. The lysosome-enriched fraction in the present study represented pooled fractions 1-5 after the second ultracentrifugation step described by Lisman et al. (1978) .
Preparation of PHICytidine Diphosphodipalmitoyl-sn-

Glycerol (f'H]CDP-Dipalrnitin)
[3H]CMP-morpholidate was prepared by the reaction of 0.5 mmol of [3H]C!MP (350 pCi/mrnol) with 2 mmol each of morpholine and of N, N '-dicyclohexylcarbodiimide, and [3H]CDP-dipalmitin was prepared from 0.3 mmol of dipalmitoyl PhA and an equimolar amount of the resultant labeled CMP morpholidate (Agranoff and Suomi, 1963) . After 4 days, the reaction mixture was dried in a rotary evaporator under reduced pressure and dissolved in chloroform/methanol/6 M-HCl (200: 100: 1, by vol.). The mixture was washed twice with an added aqueous upper phase from which unreacted [3H]CMP-morpholidate was removed. The [3H]CDP-dipalmitin product was further purified by silica gel chromatography. The lipid extract was applied to a column (10 x 1.5 cm) containing 10 g of Unisil which was treated sequentially with 200-ml volumes of chlorofordpyridinelformic acid (50:30:7, by vol.), chloroform, and chloroforndmethanol (3:2, vlv). The [3H]CDP-dipalmitin was eluted in the latter fraction and dried under reduced pressure. The product was suspended in 1 -2 ml of cold water, and an equimolar amount of Tris base was added incrementally with frequent sonication to avoid the possibility of alkaline hydrolysis of the ester bonds. The pH of the milky suspension was then adjusted to 7.4 with additional Tris if necessary, using narrow-range indicator 'paper, and then stored at 4°C. Under these conditions, less than 5% breakdown occurred over a 2-month period. Some 10-40% of the labeled morpholidate was converted to the liponucleotide. Purity of the product was in excess of 95% as judged by TLC and high-voltage electrophoresis (HVE).
Thin-Layer Chromatography
Solvent systems employed were: (A) chloroform/ methanoVacetic acidwater (50:25:7:3, by vol.) and (B) chlorofordpyridinelformic acid (50:30:7, by vol.) as described by Raetz et al. (1976) . Silica gel G or HPTLC plates (E. M. Merck) were obtained from Brinkman Industries, Des Plaines, Illinois. Lipids were visualized by lipid phosphorus spray (Dittmer and Lester, 1964) or by charring with sulfuric acid reagent (Fewster et al., 1969) .
High-Voltage Electrophoresis
Samples were applied to Whatman No. 1 filter paper in buffer and subjected to HVE at 4000 V for 30 min in the same buffer. To follow CMP-morpholidate synthesis, a 0.05 M-sodium tetraborate buffer (pH 8.7) was employed. CMP-morpholidate migrated 10 cm, while CMP migrated 14 cm. For enzyme product identification, a pyridine/ acetic acid/water mixture (14:40:356, pH 4.3) was employed. CDP-DG remained at the origin and cytosine and cytidine moved toward the cathode, while CMP and CDP migrated anodally 6 cm and 9 cm, respectively.
Assay of CDP-DG Hydrolase
The standard enzyme assay medium contained 0.1 MTris-maleate buffer (pH 4.8), 0.3% Triton X-100 (wlv), 0.28 m~-[~H]CDP-dipalmitin (0.35 mCi/mmol) and 1 -150 pg of enzyme protein in a final volume of 0.1 ml. The reaction was initiated by the addition of lipid substrate, which had been sonicated for 15 s. Assays were performed at 37°C for 30-60 min, and the reactions terminated by the addition of 1.12 ml of chforoform-methanol (1:2, vh). The lipid components of the incubation mixture were then separated from water-soluble products by the further addition of 0.025 ml of 6 M-HCI, 0.38 ml of chloroform, and 0.58 ml of H20 (Hajra et al., 1968 ). The two phases were then separated by low-speed centrifugation at room temperature, and 1.0 ml of the clear overlying aqueous layer was carefully removed and dried in a counting vial under a stream of N,. Radioactivity was determined after the addition of 1 ml of water and 10 ml of ACS scintillation cocktail (Amersham Searle, Chicago, Illinois). Counting efficiency for 3H was approximately 25%, as determined by an internal standard method. Observed enzyme activity was corrected for the amount of radioactivity present in the aqueous phase of zero time incubations (1.5 -3% of radioactivity initially added).
Assay of Marker Enzymes
Succinate dehydrogenase (EC 1.3.99.1) was determined by measuring succinate-dependent reduction of 2-
chloride (INT), using the procedure of Porteus and Clark (1965) . Acetylcholinesterase (EC 3.1.1.7) was determined by the method of Ellman et al. (1961) , with the exception that the assays included lo-,' M-tetraisopropylpyrophosphoramide to inhibit pseudocholinesterase (Hoover et al., 1978) . Choline acetyltransferase (EC 2.3.1.6) was determined by the procedure of Fonnum 
Chemical Determinations
Protein was determined spectrophotometrically (Geiger and Bessman, 1972) , using bovine serum albumin as a standard. To circumvent interference by Triton X-100 or Tris-HC1 buffer, protein was first precipitated by addition of sodium deoxycholate and trichloroacetic acid prior to estimation (Bensadoun and Weinstein, 1976) . Total lipid phosphorus was determined by the method of Ames and Dubin (1 960).
RESULTS
Characterization of CDP-DG Hydrolase
Activity in Homogenates CDP-DG hydrolase activity, as measured by the release of water-soluble radioactivity, was linear with respect to time of incubation for up to 90 min and with amounts of protein up to 150 kg under conditions of partial substrate utilization. Incubation times and amount of enzyme were subsequently maintained so that less than 25% of the substrate routinely underwent hydrolysis. The addition of Triton X-100, to a find concentration of 0.2-0.3%, stimulated enzyme activity 7-10-fold ( Fig. 1) . A broad acidic pH optimum (4.5-5.0) for enzyme activity was observed in guinea pig cerebral cortex homogenates, under which conditions specific activity was 0.33 2 0.11 nmol (s.D.) of watersoluble radioactivity released per min per mg of protein ( n = 7 ) . 
Subcellular Localization of CDP-DG Hydrolase
To establish the subcellular site of CDP-DG hydrolase activity, cerebral cortex homogenates were fractionated by differential and sucrose-density centrifugation and the subcellular fractions obtained assessed for cross-contamination, by means of specific marker enzymes. The greatest enrichment of CDP-DG hydrolase was associated with the mitochondrial-lysosomal (P2C) fraction (Table 1) . In four separate experiments, this fraction showed an R.S.A. (relative specific activity) of 4.00 2 0.48 when compared to the homogenate. The only other subcellular fraction which exhibited significant enrichment of activity was the synaptosomal fraction (R.S.A. = 1.34 -t 0.46, n = 3). The mitochondria1 marker enzymes, succinate dehydrogenase and monoamine oxidase (SDH, MAO), were enriched in the P,C fraction to an extent similar to that of CDP-DG hydrolase, although the R.S.A. values for both SDH and M A 0 were consistently lower than CDP-DG hydrolase in the synaptosomal fraction.
To ascertain whether CDP-DG hydrolase existed in a latent form, the P2C fraction was subjected to rapid freeze-thaw treatment. As shown in Table 2 , this procedure resulted in an almost quantitative release of CDP-DG hydrolase activity into the soluble fraction, along with two lysosomal marker enzymes, P-galactosidase and p-glucuronidase. In marked contrast, the freeze-thaw treatment released little or no SDH or MA0 activity from the P2C fraction and, in fact, resulted in a significant enrichment of these enzymes in the particulate fraction. Further evidence to suggest a lysosomal localization for CDP-DG hydrolase was obtained H . G. RITTENHOUSE ET AL. Subcellular fractions were prepared as described in Materials and Methods and assayed for CDP-diglyceride hydrolase and marker enzyme activities. The relative specific activity is defined as the specific activity of the fraction relative to that of homogenate. Actual specific activities (nmoVmg proteidmin) in the homogenate were as follows: CDP-diglyceride hydrolase, 0.27; monoamine oxidase, 1.98; succinate dehydrogenase, 14.7; choline acetyltransferase, 0.74; acetylcholinesterase, 82.0. Protein in homogenate was 112 mgig wet weight. Results are from one of three experiments that gave similar results.
from subcellular fractionation experiments involving the "chemical field" method, whereby the sedimentation rate of mitochondria is increased by the addition of succinate, facilitating the separation of lysosomes from contaminating mitochondria. Using this technique, lysosomal fractions obtained from the crude mitochondrial fraction (P2) were enriched in both @-galactosidase (R.S.A. = 3.85) and CDP-DG hydrolase (R.S.A. = 3.03) and contained only small amounts of SDH (R.S.A. = 0.68). In agreement with the findings of Lisman et al. (1978) , they retained significant MA0 activity (R.S.A. = 2.06), indicating contamination of the fraction with detached outer mitochondrial membranes.
Purification of CDP-DG Hydrolase
The P,C fraction obtained from three guinea pig cerebral cortices was routinely used as the starting preparation for enzyme purification, and was dialyzed at 4°C against at least two 1-liter changes of 1 mM-sodium phosphate buffer (pH 7.4) over a 24-h period. The dialysand was rapidly frozen in an acetone-Dry Ice bath and thawed three times, and the suspension centrifuged at 14,500 g for 20 min. The supernatant fraction was drawn off carefully in order to avoid contamination of the pelleted debris. More than 85% of the initial CDP-DG hydrolase activity present was recovered in a soluble form, yielding a 16.5-fold enrichment over the total homogenate (Table 3) . Additional freeze-and-thaw tteatment of the P,C fraction did not release further enzyme activity. The preparation was unstable at 4°C or -20°C at this step. The solubilized enzyme was diluted 10-fold with 1 mM-sodium phosphate buffer (pH 7.4) and transferred to an Amicon Model 12 stirred ultrafiltration cell containing an XM-300 membrane (nominal mol. wt. cutoff >300,000). The solution was concentrated to approximately I ml at less than 8 psi. The concentrated enzyme was diluted to 10 ml with 10 mM-Tris-HCi buffer (pH 7.4) and concentrated to less than 1 ml by a repetition of the ultrafiltration step. The retentate contained more than 80% of the applied hydrolase activity and had a specific activity approximately twofold that of the supernatant fraction from the freeze-thaw Mitochondrial-lysosomal fraction (P,C) was frozen and thawed three times in an acetone-Dry Ice bath and centrifuged at 14,500 g for 20 min to obtain particulate and supernatant fractions. CDP-diglyceride hydrolase and marker enzyme activities were then measured in these fractions in addition to initial homogenate. Values expressed are relative specific activities. Actual specific activities in the homogenate (nmoYmg proteidmin) were as follows: CDP-diglyceride hydrolase, 0.30; succinate dehydrogenase, 18.5; monoamine oxidase, 5.2; p-glucuronidase, 0.29; p-galactosidase, 0.41. Results are from one of two experiments that gave similar results. N.D., not detectable. treatment. The XM-300 retentate lost more than 25% activity after storage at 4°C for 24 h in the absence of detergent, but could be stabilized by the addition of Triton X-100 to a final concentration of 0.2%. Chromatography of the XM-300 retentate fraction on a DEAE-cellulose column resulted in a sharp peak of hydrolase activity emerging from the column at 0.025-0.05 M-NaCl (Fig. 2) . More than 90% of the activity recovered was present in fractions 3 and 4. These combined fractions constituted a twofold purification relative to the XM-300 retentate. The specific activity of the most active fraction (3) was increased more than fourfold relative to the XM-300 retentate fraction. In some experiments the peak of CDP-DG hydrolase activity was eluted from the column in fraction 4 rather than fraction 3, and therefore both were routinely combined.
The pooled fractions were concentrated and freed of excess Triton X-100 by ultrafiltration, using a Diaflo PM-10 membrane in an Amicon model 12 I u C stirred ultrafiltration cell, at less than 40 psi. Before ultrafiltration, the pooled fractions were diluted to 30 ml with 10 mM-Tris-HC1 (pH 7.4), containing 30% ethylene glycol (wh) and 10% ethanol in order to break up the Triton X-100 micelles (Frasch, 1975) . To remove remaining detergent, the enzyme was concentrated to 1 ml and diluted to 10 ml with 10 mM-Tris-HC1 (pH 7.4) containing 30% ethylene glycol (wh) and 10% ethanol, and concentrated again to 1 ml. The concentrated enzyme was then washed in the same manner with two 10-ml portions of 1 mM-sodium phosphate buffer (pH 7.4) to remove the ethylene glycol and ethanol. The purified enzyme remained unstable in the absence of detergent, and the final enzyme concentrate (1 ml) was made 0.2% in Triton X-100. More than 80% of the enzyme activity in the pooled fractions following DEAE-cellulose chromatography was recovered following ultrafiltration and represented a 90-fold enrichment of activity relative to the initial homogenate. The purified enzyme was stable for at least 4 
Identification of Products
In order to eliminate possible complications due to the presence in the homogenate of nucleotidases and PhA phosphohydrolase activities, product identification was carried out with purified PM-10 retentate fraction. An incubation mixture containing 56 nmol of [3H]CDP-dipalmitin was incubated for 4.5 h at pH 4.8 in the standard enzyme assay mixture. Following addition of the acidified chloroform-methanol and separation of phases, a 0.5-ml aliquot of the aqueous layer was dried under Nz, dissolved in 0.05 ml of HzO, and subjected to high-voltage electrophoresis at pH 4.3 with CMP, CDP, and cytidine standards. The derivatives were located by UV absorption, cut out, and counted. All of the recovered activity was found in the CMP spot. The organic layer from the extracted incubation mixture was dried under Nz, redissolved in chloroform-methanol (2:1), and applied to a TLC plate in solvent system B, together with standards of PhA, lyso-PhA, and diacyl glycerol. Areas corresponding to lipid markers were scraped and transferred to Pasteur pipet columns plugged with glass wool. Lipids were eluted with two 5-ml volumes of chlorofordmethanol (3:2) and total phosphate was determined. A single lipid phosphorus spot with an Rf of 0.5 was found, which corresponds to that of authentic dipalmitoyl PhA. CDP-DG remains at the origin in this system. With solvent system A, the product co-migrated with authentic PhA with an R f of 0.83, while CDP-DG, lyso-PhA, and diacylglycerol had R;s of 0.28, 0.47 and 1.0, respectively. A very faint spot was seen in the lyso-PhA region. Stoichiometry was calculated by comparison of aqueous phosphate released with that lost from the organic phase during a 6-h incubation in which >90% of CDP-DG was utilized (theoretical, 1.00; found, 1.07).
Properties of the Purified Enzyme
The PM-10 retentate fraction displayed normal Michaelis-Menten kinetics towards CDP-dipalmitin in the concentration range 0.023-0.92 mM. A K , value of 45 PM was calculated from linear regression analysis of double-reciprocal plots (Fig. 3) . The pH optimum was 4.8 (Fig. 4) . Neither K+ nor Na+ ions (1 mM) had a significant effect on the hydrolase, while all divalent cations tested were inhibitory. HgZ+ was most potent, and produced 75% inhibition, whereas Mg2+ was least inhibitory (16%).
Other ions in order of descending inhibition were Mn2+, Cu2+ Ca2+, and Zn2+. The addition of either 5 mM-EDTi or -EGTA in the absence of added divalent cations did not affect enzyme activity.
Substrate Specificity A number of potential substrates and inhibitors were examined with the purified enzyme for their possible effects on CDP-DG hydrolase. Of the liponucleotides, both dCDP-DG and ADP-DG were strongly inhibitory (Table 4) . In separate experiments, it was shown that radioactively labeled dCDP-DG was itself hydrolyzed by the enzyme at 20% the rate observed with CDP-DG. In contrast, CDP-choline, CDP-glycerol, and sodium pyrophosphate were not inhibitory. In view of the inhibition of the enzyme by AMP in the present experiments as we11 as of the bacterial enzyme (Raetz et al., 1976 ) structural analogs of this nucleotide were investigated. Both 5'-AMP and 5'-dAMP produced strong inhibition (over 90%), while a mixture of 2'-and 3'-AMP was less inhibitory. Substitution of the 5'-phosphate by sulfate destroyed the inhibitory effect. While ATP produced some inhibition, the a,p-methylene derivative was not inhibitory, a result suggesting that some degradation of ATP to AMP may account for the observed inhibition. The p,y-methylene derivative of ATP, which is easily hydrolyzed to AMP, was inhibitory. Ara-C, a potential chemotherapeutic agent (Raetz et al., 1977) was inhibitory, as were both ara-CMP and ara-AMP. Ara-A was without effect. Adenosine 5'-0-thiomonophosphate was as effective an inhibitor as AMP.
Tissue Distribution of CDP-DG Hydrolase CDP-DG hydrolase activities were detected in dialyzed homogenates of all organs tested. Spleen and brain extracts had comparable specific activities, while lung, kidney, heart, and liver were only slightly less active.
DISCUSSION
The data presented are consistent with the presence in eukaryotic tissues of CDP-DG hydrolase activity. The brain enzyme appears to be lysosomal as judged from its distribution in subcellular fractions, its release upon freeze-thaw treatment, and its acidic pH optimum. It is unlikely that the observed activity could be accounted for by the action of other enzymes of CDP-DG metabolism. CTP:PhA cytidyl transferase purified from yeast (Belendiuk et al., 1978) or E. coli (Langley and Kennedy, 1978) has no CDP-DG hydrolase activity. In addition, the brain CDP-DG hydrolase preparation is not affected by the addition of inorganic pyrophosphate and has no divalent cation requirement. The lack of a metal requirement, the distribution of the hydrolase in brain subcellular fractions, and the observed pH optimum also rule out a role for CDP-DG:inositol transferase in the observed hydrolytic activity. Furthermore, the addition of 1 mM-inositol did not stimulate release of watersoluble radioactivity. The observed lysosomal distribution also speaks against the possibility that the observed activity can be attributed to a nonspecific nucleotide pyrophosphatase, since this class of enzymes is characterized by a somewhat alkaline pH optimum, a localization in microsomal and plasma membrane fractions and frequently, but not invariantly, a divalent cation requirement (Schliselfeld et al., 1965; Bischoff et al., 1975) . The brain CDP-DG hydrolase was also unaffected by the presence of a 10-fold excess of CDP-choline.
The conversion of CDP-DG to phosphatidylinositol (PhI) catalyzed by CDP-DG:inositol transferase has been demonstrated to be reversible (Petzold and Agranoff, 1965; 1967) . The reverse reaction, coupled with CDP-DG hydrolase, yields a phospholipase D-like conversion of PhI to PhA and myo-inositol:
A phospholipase D action in the pancreas has been invoked to explain a "phospholipid labeling effect," i.e., increased labeling of PhI and PhA from 32Pi (Hokin-Neaverson et al., 1978) . In pancreas, unlike brain, a net decrease in the amount of PhI and commensurate increase in PhA is seen following addition of cholecystokinin (pancreazymin) or acetylcholine. Different intracellular localizations and pH optima for the hydrolase and transferase, however, render this hypothesis less attractive. The brain enzyme differs from bacterial CDP-DG hydrolase in a number of ways. The bacterial enzyme is not reported to have an acidic pH optimum, is inactive against dCDP-DG, and is not inhibited by the deoxy-liponucleotide (Raetz, 1972) . In contrast, the present studies indicate that the brain enzyme cleaves dCDP-DG, and CDP-DG hydrolysis is blocked by the presence of dCDP-DG.
dCDP-DG is found in bacteria in equimolar amounts with CDP-DG (Raetz et al., 1976) . The CTP:PhA cytidyl transferase of bacteria accepts dCTP and CTP equally well, and both nucleotides can be utilized to form bacterial lipids. Since there is much more CTP available in bacteria than dCTP, it has been suggested that the differential action of the hydrolase may be responsible for the unexpectedly high levels of dCDP-DG found in bacteria. The significance of the two precursors, seemingly equally suitable, is unknown. In yeast, the CTP:PhA cytidyl transferase accepts only CTP as a substrate and hence dCDP-DG is not found. In liver and brain, both triphosphates are accepted, but only CDP-DG has so far been isolated from tissue. The absence of dCDP-DG in animals can be accounted for by the relatively low amount of dCTP available for dCDP-DG synthesis, since the hydrolase in brain (unlike bacteria) can utilize both CDP-DG and dCDP-DG as substrates.
Of the various enzymes of liponucleotide metabolism, those of synthesis appear rate-limiting, a concept supported by the low steady state levels of liponucleotides in sources, so far examined. Hydrolase rates are generally of the order of, or greater than, lipid biosynthetic reactions (Carter and Kennedy, 1966;  Petzold and Agranoff, 1967) . The highly specific inhibition by AMP in both bacterial and mammalian enzymes is unexplained, but may be related to a regulatory mechanism.
The presence of CDP-DG hydrolase in brain was postulated previously by Eliasson et al. (1972) , who found that brain from rabbits with a hereditary ataxia was inefficient in producing PhI from added CDP-DG precursor. It is possible that the pathological changes in the animals led to increased lysosomal content secondary to degenerative changes and, hence, to increased CDP-DG hydrolase activity.
Liponucleotides have been proposed as convenient forms for the introduction of chemotherapeutic agents. For example, ara-C has been introduced into experimental animals in the form of ara-CDP-DG liposomes (Raetz et al., 1977) . It is proposed that the micelles are readily picked up by cells and then cleaved by CDP-DG:inositol transferase to form ara-CMP and phosphatidylinositol, thus additionally bypassing the nucleoside kinase step, thought to be rate-limiting. From the present experiments, it appears more likely that the ara-CDP-DG is cleaved by CDP-DG hydrolase. If the micelles are picked up by endocytosis, they are likely to come in contact with lysosomal enzymes immediately upon entry into the cell. Although the activity of mammalian CDP-DG hydrolase against ara-CDP-DG is as yet unknown, this possibility should be given consideration in view of the low specificity of the mammalian enzyme.
Note added in proof:
In subsequent experiments, the apparent K M toward CDP-dipalmitin has varied from 64 to 127 PM, possibly reflecting the lipid content in a given preparation of partially purified enzyme.
